Stanley Laman Group, Ltd. Castle Biosciences Inc Transaction History

Stanley Laman Group, Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$16.0 - $45.99 $58,544 - $168,277	3,659 Added 9.1%	43,875 $963,000
Q1 2022 Apr 21, 2022	BUY	$33.17 - $46.98 $8,027 - $11,369	242 Added 0.61%	40,216 $1.8 Million
Q4 2021 Jan 25, 2022	BUY	$39.06 - $67.58 $1.56 Million - $2.7 Million	39,974 New	39,974 $1.71 Million

210

26.6M

128K

35.4K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $677M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stanley Laman Group, Ltd. with notifications on news.